Illumina Inc
DUS:ILU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Illumina Inc (ILU) under the Base Case is EUR per share.
Compared with the current market price of 196.6 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Illumina Does
Illumina makes DNA sequencing systems and the consumables that run on them. Its machines read genetic code, and its test kits and reagents are used to prepare samples and generate sequencing data. The company mainly sells to hospitals, research labs, biotech companies, and clinical testing groups that need to analyze DNA for science or diagnosis.
- Headquarters
- United States of America US
- Employees
- 8 600
- IPO date
- Jun 28, 2000
Illumina has a narrow economic moat
Replacing Illumina equipment can mean rebuilding laboratory routines, retraining staff and checking that tests still produce reliable results, making a cheaper rival costly to adopt. Patents also prevent competitors from directly copying protected parts of its sequencing technology. These barriers help protect repeat purchases of supplies, rather than keeping competing systems out entirely.
Read the full moat analysis
Revenue & Expenses Breakdown
Illumina Inc
Earnings Waterfall
Illumina Inc
What is the Intrinsic Value of one ILU stock?
The intrinsic value for Illumina Inc (ILU) under the Base Case is EUR.
Is ILU stock undervalued or overvalued?
Compared with the current market price of 196.6 EUR, the stock appears .
